logo-loader
AIM:AMYT

Amryt Pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£220.16 m
Price
142.50 GBX
Change
0.00%
52 weeks high
145.00
52 weeks low
80.00

In brief

Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases.

Deep dive We explore the investor case for growth companies

Snapshot

  • A revenue-generating orphan drugs company
  • Completed a transformational deal
  • Expected to be a high growth business